Bayesian Capital Management’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
+3,300
New +$244K 0.17% 165
2025
Q2
Sell
-13,000
Closed -$166K 545
2025
Q1
$166K Buy
+13,000
New +$236K 0.03% 511
2024
Q2
Sell
-25,303
Closed -$724K 721
2024
Q1
$724K Buy
+25,303
New +$809K 0.07% 356
2023
Q2
Sell
-32,682
Closed -$830K 786
2023
Q1
$830K Buy
+32,682
New +$1.03M 0.1% 270
2020
Q4
Sell
-6,966
Closed -$300K 453
2020
Q3
$300K Buy
+6,966
New +$301K 0.07% 344
2020
Q2
Sell
-11,334
Closed -$326K 525
2020
Q1
$326K Buy
11,334
+6,500
+134% +$262K 0.07% 421
2019
Q4
$307K Buy
+4,834
New +$240K 0.05% 421

Other funds holding ARWR

Bayesian Capital Management's ARWR Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Arrowhead Research (ARWR) in Q2 2026: 3,300 shares worth $269K. The stake represents 0.17% of the portfolio and ranks #165 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in ARWR as recently as Q1 2025.

Bayesian Capital Management first reported a position in ARWR in Q4 2019 and has held it in 7 quarters since. The position peaked at $830K in Q1 2023. 501 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

  • Bayesian Capital Management held 3,300 shares of Arrowhead Research worth $269K as of Q2 2026.
  • Arrowhead Research was a new Bayesian Capital Management position in Q2 2026.
  • Arrowhead Research made up 0.17% of Bayesian Capital Management's portfolio in Q2 2026, its #165 holding.
  • Bayesian Capital Management first reported a position in Arrowhead Research in Q4 2019 and has held it in 7 quarters since.
  • Bayesian Capital Management's Arrowhead Research position peaked at $830K in Q1 2023.
  • 501 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.